Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Popeye domain-containing protein 1 (POPDC1/BVES) is a transmembrane cAMP effector protein highly expressed in striated muscle and cardiac tissue. It binds cAMP with high affinity and modulates the trafficking and function of other membrane proteins, particularly the TREK-1 potassium channel, influencing muscle cell membrane potential and excitability. Disease-causing mutations in POPDC1 disrupt its membrane localization or cAMP responsiveness, resulting in limb-girdle muscular dystrophy and heart conduction abnormalities. POPDC1 acts as an adaptor/scaffold for adenylyl cyclase 9 (AC9) and affects local cAMP signaling domains, with loss-of-function leading to pathogenic alterations in muscle and cardiac function. It does not currently have direct therapeutic interventions, but its genetic variants are important biomarkers for related channelopathies and muscular dystrophies.
Modulation of cAMP binding alters membrane localization and potassium channel activity in muscle/cardiac cells. Drug-induced changes in cAMP (e.g., with theophylline) disrupt POPDC1 influence on channel trafficking/function.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Popeye domain-containing protein 1 (POPDC1).